Development of anti-TNF therapy for rheumatoid arthritis.
The aetiology of systemic, autoimmune, chronic inflammatory diseases--such as rheumatoid arthritis--is not known, and their pathogenesis is complex and multifactorial. However, progress in the characterization of intercellular mediators--proteins that are now known as cytokines--has led to the reali...
Huvudupphovsman: | Feldmann, M |
---|---|
Materialtyp: | Journal article |
Språk: | English |
Publicerad: |
2002
|
Liknande verk
-
ANTI TNF THERAPY IN RHEUMATOID ARTHRITIS
av: Feldmann, M, et al.
Publicerad: (2011) -
TNF-alpha in rheumatoid arthritis and prospects of anti-TNF therapy.
av: Maini, R, et al.
Publicerad: (1993) -
Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis.
av: Taylor, P, et al.
Publicerad: (2009) -
Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?
av: Feldmann, M, et al.
Publicerad: (2001) -
Insights into the pathogenesis of rheumatoid arthritis from application of anti-TNF therapy.
av: Maini, R, et al.
Publicerad: (2000)